Style de citation APA (7e éd.)

HM, C., PY, C., CH, C., & HC, T. (2021). Outcomes After Switching to BIC/FTC/TAF in Patients with Virological Failure to Protease Inhibitors or Non-Nucleoside Reverse Transcriptase Inhibitors: A Real-World Cohort Study. Dove Medical Press.

Style de citation Chicago (17e éd.)

HM, Chang, Chou PY, Chou CH, et Tsai HC. Outcomes After Switching to BIC/FTC/TAF in Patients with Virological Failure to Protease Inhibitors or Non-Nucleoside Reverse Transcriptase Inhibitors: A Real-World Cohort Study. Dove Medical Press, 2021.

Style de citation MLA (8e éd.)

HM, Chang, et al. Outcomes After Switching to BIC/FTC/TAF in Patients with Virological Failure to Protease Inhibitors or Non-Nucleoside Reverse Transcriptase Inhibitors: A Real-World Cohort Study. Dove Medical Press, 2021.